KALC Special Membership Offer

The IASLC is excited to work with the Korean Association for Lung Cancer (KALC) to offer joint membership. 

Become a Member

This promotion provides two possible discounted membership rates for one-year or three-year IASLC membership: 

  • Option 1: 1-year Regular Membership (US$75.00) - Includes all benefits of IASLC Membership, except this is a non-voting membership.  This membership will expire December, 31, 2019.
  • Option 2: 3-year Regular Membership (US$375.00) - Includes all benefits of IASLC Membership, including voting in election years, and WCLC member discounts in all 3 years of membership.  This membership will expire December 31, 2021./li>
  • Option 3: 1-year Nurses & Allied Health Professionals Membership ($25.00) (online-only) is $25.00 (half-price)

This offer is available to members of the KALC who are joining IASLC for the first time. These memberships will provide discounted registration at all IASLC Meetings throughout the duration of the membership, including the 2019 World Conference on Lung Cancer in Barcelona, Spain, as well as the membership benefits described below. We look forward to many interactions between the IASLC and KALC.

Membership Offer Details

Who is Eligible?
 Active members of KALC who have not previously been a member of IASLC. This offer is provided to you in recognition of the relationship of KALC and IASLC over many years.

Benefits include: Print and Online JTO and all Supplements; Member Discounts to all IASLC Meetings, including WCLC 2019 in Barcelona, Spain; IASLC Member Newsletter; ability to serve on IASLC Committees; eligibility to apply for fellowship funding and much more! Learn more at http://www.iaslc.org or contact us with questions.  NOTE: 1-year discounted KALC membership is non-voting membership.

How to apply: (1) Complete the IASLC online membership and make sure to select the member type titled "KASLC Membership 2019" or "KALC Membership 2019-2021."  (2) Or, contact IASLC membership membership@iaslc.org  for assistance.